Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
8 min read
GPR84 Biologics Sequence Review Report 2026: G protein-coupled receptor 84 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR84 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR83 Biologics Sequence Review Report 2026: G protein-coupled receptor 83 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR83 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR65 Biologics Sequence Review Report 2026: G protein-coupled receptor 65 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR65 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR78 Biologics Sequence Review Report 2026: G protein-coupled receptor 78 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR78 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR75 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 75 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR75 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR68 Biologics Sequence Review Report 2026: G protein-coupled receptor 68 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR68 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
ADAMTS4 Biologics Sequence Review Report 2026: A disintegrin and metalloproteinase with thrombospondin motifs 4 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of ADAMTS4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR45 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 45 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR45 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR61 Biologics Sequence Review Report 2026: G protein-coupled receptor 61 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR61 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
LILRB3 Biologics Sequence Review Report 2026: Leukocyte immunoglobulin-like receptor subfamily B member 3 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of LILRB3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR62 Biologics Sequence Review Report 2026: G protein-coupled receptor 62 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR62 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR63 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 63 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR63 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.